Cencora Inc. Market Cap ($61.32 Billion)
Market Cap & Net Worth: Cencora Inc. (COR)
Cencora Inc. market cap. Cencora Inc. (NYSE:COR) has a market capitalization of $61.32 Billion ($61.32 Billion) as of November 6, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #446 globally and #227 in its home market, demonstrating a 4.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cencora Inc.'s stock price $339.68 by its total outstanding shares 190827165 (190.83 Million). Also see COR cash generation efficiency for how efficiently the company converts equity into cash flow.
Cencora Inc. Market Cap History (2015–2026)
Cencora Inc. market cap history from 2015 to 2026. Data shows growth from $17.27 Billion to $64.82 Billion (13.66% CAGR). Check current stock price of Cencora Inc. for real-time trading data and today's change.
Index Memberships
Cencora Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$60.15 Trillion | 0.11% | #180 of 503 |
Weight: Cencora Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cencora Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cencora Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore COR shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.20x
Cencora Inc.'s market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
41.47x
Cencora Inc.'s market cap is 41.47 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.24 Billion | $146.85 Billion | $1.43 Billion | 0.09x | 9.28x |
| 2017 | $15.83 Billion | $153.14 Billion | $414.48 Million | 0.10x | 38.19x |
| 2018 | $13.05 Billion | $167.94 Billion | $1.66 Billion | 0.08x | 7.87x |
| 2019 | $15.20 Billion | $179.59 Billion | $855.37 Million | 0.08x | 17.77x |
| 2020 | $17.79 Billion | $189.89 Billion | -$3.40 Billion | 0.09x | N/A |
| 2021 | $24.55 Billion | $213.99 Billion | $1.54 Billion | 0.11x | 15.94x |
| 2022 | $31.00 Billion | $238.59 Billion | $1.70 Billion | 0.13x | 18.25x |
| 2023 | $38.85 Billion | $262.17 Billion | $1.75 Billion | 0.15x | 22.26x |
| 2024 | $42.88 Billion | $293.96 Billion | $1.51 Billion | 0.15x | 28.41x |
| 2025 | $64.45 Billion | $321.33 Billion | $1.55 Billion | 0.20x | 41.47x |
Competitor Companies of COR by Market Capitalization
Companies near Cencora Inc. in the global market cap rankings as of November 6, 2026. Also see Cencora Inc. asset portfolio for a full breakdown of the balance sheet.
Key companies related to Cencora Inc. by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #245 globally with a market cap of $101.38 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #620 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1123 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
- Sigma Healthcare Limited (F:S5YA): Ranked #1255 globally with a market cap of $19.74 Billion USD ( €16.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #245 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $1072.00 |
| #620 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $267.82 |
| #1123 | Sigma Healthcare Ltd | AU:SIG | $23.03 Billion | AU$2.82 |
| #1255 | Sigma Healthcare Limited | F:S5YA | $19.74 Billion | €1.70 |
Market Capitalization of Cencora Inc. (2015–2026)
Market capitalization of Cencora Inc. from 2015 to today. Between 2015 and today, Cencora Inc.'s market cap moved from $17.27 Billion to $ 64.82 Billion, with a yearly change of 13.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $64.82 Billion | +0.57% |
| 2025 | $64.45 Billion | +50.32% |
| 2024 | $42.88 Billion | +10.37% |
| 2023 | $38.85 Billion | +25.33% |
| 2022 | $31.00 Billion | +26.26% |
| 2021 | $24.55 Billion | +38.01% |
| 2020 | $17.79 Billion | +17.03% |
| 2019 | $15.20 Billion | +16.48% |
| 2018 | $13.05 Billion | -17.57% |
| 2017 | $15.83 Billion | +19.51% |
| 2016 | $13.24 Billion | -23.32% |
| 2015 | $17.27 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Cencora Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $61.32 Billion USD |
| MoneyControl | $61.32 Billion USD |
| MarketWatch | $61.32 Billion USD |
| marketcap.company | $61.32 Billion USD |
| Reuters | $61.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more